These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8836298)

  • 1. Secondary parkinsonism due to focal substantia nigra lesions: a PET study with [18F]FDG and [18F]fluorodopa.
    Boecker H; Weindl A; Leenders K; Antonini A; Kuwert T; Kruggel F; Grafin von Einsiedel H; Conrad B
    Acta Neurol Scand; 1996 Jun; 93(6):387-92. PubMed ID: 8836298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
    Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
    Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies.
    Eidelberg D; Moeller JR; Dhawan V; Sidtis JJ; Ginos JZ; Strother SC; Cedarbaum J; Greene P; Fahn S; Rottenberg DA
    Mov Disord; 1990; 5(3):203-13. PubMed ID: 2117706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of familial juvenile dystonia-parkinsonism: 18F-6-fluorodopa and 18F-fluoro-2-deoxyglucose PET study].
    Hanakawa T; Fukuyama H; Akiguchi I; Kato M; Kimura J; Shibasaki H
    Rinsho Shinkeigaku; 1996 May; 36(5):655-60. PubMed ID: 8905984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
    Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
    Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease.
    Kaasinen V; Maguire RP; Hundemer HP; Leenders KL
    J Neurol; 2006 Mar; 253(3):340-8. PubMed ID: 16222426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG.
    Otsuka M; Kuwabara Y; Ichiya Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K
    Ann Nucl Med; 1997 Aug; 11(3):251-7. PubMed ID: 9310175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration.
    Laureys S; Salmon E; Garraux G; Peigneux P; Lemaire C; Degueldre C; Franck G
    J Neurol; 1999 Dec; 246(12):1151-8. PubMed ID: 10653307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography in degenerative disorders of the dopaminergic system.
    Karbe H; Holthoff V; Huber M; Herholz K; Wienhard K; Wagner R; Heiss WD
    J Neural Transm Park Dis Dement Sect; 1992; 4(2):121-30. PubMed ID: 1571076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome.
    Przedborski S; Giladi N; Takikawa S; Ishikawa T; Dhawan V; Spetsieris P; Chaly T; Fahn S; Eidelberg D
    Neurology; 1994 Sep; 44(9):1622-8. PubMed ID: 7936286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal dopa and glucose metabolism in PD patients with freezing of gait.
    Bartels AL; de Jong BM; Giladi N; Schaafsma JD; Maguire RP; Veenma L; Pruim J; Balash Y; Youdim MB; Leenders KL
    Mov Disord; 2006 Sep; 21(9):1326-32. PubMed ID: 16721756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
    Pirker W
    Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
    Perani D; Bressi S; Testa D; Grassi F; Cortelli P; Gentrini S; Savoiardo M; Caraceni T; Fazio F
    Arch Neurol; 1995 Feb; 52(2):179-85. PubMed ID: 7848128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monosymptomatic resting tremor and Parkinson's disease: a multitracer positron emission tomographic study.
    Ghaemi M; Raethjen J; Hilker R; Rudolf J; Sobesky J; Deuschl G; Heiss WD
    Mov Disord; 2002 Jul; 17(4):782-8. PubMed ID: 12210876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased striatal 18F-dopa uptake and normal glucose metabolism in idiopathic dystonia syndrome.
    Otsuka M; Ichiya Y; Shima F; Kuwabara Y; Sasaki M; Fukumura T; Kato M; Masuda K; Goto I
    J Neurol Sci; 1992 Sep; 111(2):195-9. PubMed ID: 1431986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.
    Antonini A; Leenders KL; Vontobel P; Maguire RP; Missimer J; Psylla M; Günther I
    Brain; 1997 Dec; 120 ( Pt 12)():2187-95. PubMed ID: 9448574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease.
    Eidelberg D; Takikawa S; Moeller JR; Dhawan V; Redington K; Chaly T; Robeson W; Dahl JR; Margouleff D; Fazzini E
    Ann Neurol; 1993 May; 33(5):518-27. PubMed ID: 8498828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [18F] FDOPA PET may confirm the clinical diagnosis of Parkinson's disease by imaging the nigro-striatal pathway and the sympathetic cardiac innervation: Proof-of-concept study.
    Kuten J; Linevitz A; Lerman H; Freedman N; Kestenbaum M; Shiner T; Giladi N; Even-Sapir E
    J Integr Neurosci; 2020 Sep; 19(3):489-494. PubMed ID: 33070528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism.
    Otsuka M; Ichiya Y; Hosokawa S; Kuwabara Y; Tahara T; Fukumura T; Kato M; Masuda K; Goto I
    J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):898-904. PubMed ID: 1744644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.
    Lang AE
    Mov Disord; 1995 Jul; 10(4):489-95. PubMed ID: 7565831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.